Lv5
1350 积分 2023-09-08 加入
Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment
16天前
已完结
Endocrinopathies Related to Immune Checkpoint Inhibitors
16天前
已完结
Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis
16天前
已完结
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option
30天前
已完结
Immune-Mediated Diabetes Mellitus, Diabetic Ketoacidosis, Enteritis, and Thrombotic Thrombocytopenic Purpura Presenting as Adverse Effects of Pembrolizumab Therapy
30天前
已完结
Immune-related adverse events associated with cancer immunotherapy
30天前
已完结
Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board
30天前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
30天前
已完结
Management of Immunotherapy-induced Type 1 Diabetes
30天前
已完结
皖公网安备34019202002308
